Jiwei Liu
- Molecular Biology top 10%
- Oncology top 5%
- Pulmonary and Respiratory Medicine top 10%
- Cancer Research top 10%
- Immunology
- Topics
- Lung Cancer Treatments and Mutations (10 papers)Ubiquitin and proteasome pathways (9 papers)Lung Cancer Research Studies (8 papers)
- Partner nations
- ChinaUnited StatesSingapore
In The Last Decade
Jiwei Liu
58 papers receiving 1.4k citations
Peers
Comparison fields: 5 of 96
- Molecular Biology 797
- Oncology 521
- Pulmonary and Respiratory Medicine 322
- Cancer Research 289
- Immunology 198
Countries citing papers authored by Jiwei Liu
This map shows the geographic impact of Jiwei Liu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jiwei Liu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jiwei Liu more than expected).
Fields of papers citing papers by Jiwei Liu
This network shows the impact of papers produced by Jiwei Liu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jiwei Liu. The network helps show where Jiwei Liu may publish in the future.
Co-authorship network of co-authors of Jiwei Liu
This figure shows the co-authorship network connecting the top 25 collaborators of Jiwei Liu. A scholar is included among the top collaborators of Jiwei Liu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jiwei Liu. Jiwei Liu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 0 | |
| 3 | 12 | |
| 4 | 3 | |
| 5 | 3 | |
| 6 | 5 | |
| 7 | 29 | |
| 8 | 12 | |
| 9 | 14 | |
| 10 | 8 | |
| 11 | 23 | |
| 12 | 13 | |
| 13 | 99 | |
| 14 | 87 | |
| 15 | 86 | |
| 16 | 139 | |
| 17 | 37 | |
| 18 | 43 | |
| 19 | 7 | |
| 20 | 23 |
About Jiwei Liu
Jiwei Liu is a scholar working on Oncology, Internal Medicine and Cancer Research, having authored 65 papers that have together received 1.4k indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (10 papers), Ubiquitin and proteasome pathways (9 papers) and Lung Cancer Research Studies (8 papers). The work is most often cited by research in Cancer Research (289 citations), Oncology (521 citations) and Molecular Biology (797 citations). Jiwei Liu has collaborated with scholars based in China, United States and Singapore. Frequent co-authors include Qiu Yan, Aman Wang, Di Wang, Xiu Shan, Xiaoqi Wang, Zhen Ning, Xiaodong Li, Lili Tian, Qun Chen and Yi Zhao. Their work appears in journals such as Journal of Clinical Oncology, PLoS ONE and Journal of Hazardous Materials.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.